FLASH SALE! 50% Off PremiumSubscription Claim Offer ⏰ 0d 00h 00m 00s

Halozyme Therapeutics Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -49.78. In total, the insiders bought 209 752 and sold 607 831 HALO shares in the last 100 trades.

Insider Power

(Last 100 transactions)
-49.78
Buy 209 752 Shares
Sell 607 831 Shares

Historical Insider Trades

Date Type Action Person Amount
Jan 06, 2025 Common Stock Sell Henderson Jeffrey William 10 000
Jan 03, 2025 Common Stock Buy Snyder Mark Howard 7 611
Jan 03, 2025 Common Stock Sell Snyder Mark Howard 4 289
Jan 03, 2025 Restricted Stock Units Sell Snyder Mark Howard 7 611
Nov 29, 2024 Common Stock Sell Matsui Connie 10 470
Nov 29, 2024 Common Stock Sell Torley Helen 10 000
Oct 16, 2024 Common Stock Buy Labarre Michael J. 10 000
Oct 16, 2024 Common Stock Sell Labarre Michael J. 10 000
Oct 16, 2024 Option to Purchase Common Stock Sell Labarre Michael J. 10 000
Oct 15, 2024 Common Stock Buy Labarre Michael J. 5 509
Oct 15, 2024 Common Stock Sell Labarre Michael J. 9 923
Oct 15, 2024 Common Stock Sell Labarre Michael J. 77
Oct 15, 2024 Option to Purchase Common Stock Sell Labarre Michael J. 4 491
Oct 15, 2024 Option to Purchase Common Stock Sell Labarre Michael J. 5 509
Oct 09, 2024 Common Stock Buy Torley Helen 10 000
Oct 09, 2024 Common Stock Sell Torley Helen 5 981
Oct 09, 2024 Common Stock Sell Torley Helen 1 615
Oct 09, 2024 Common Stock Sell Torley Helen 2 404
Oct 09, 2024 Option to Purchase Common Stock Sell Torley Helen 10 000
Oct 08, 2024 Common Stock Sell Torley Helen 9 100
Oct 08, 2024 Common Stock Sell Torley Helen 900
Oct 08, 2024 Option to Purchase Common Stock Sell Torley Helen 10 000
Sep 26, 2024 Common Stock Buy Torley Helen 10 000
Sep 26, 2024 Common Stock Sell Torley Helen 10 000
Sep 26, 2024 Option to Purchase Common Stock Sell Torley Helen 10 000
Click to get the best stock tips daily for free!
ABOUT HALOZYME THERAPEUTICS
Halozyme Therapeutics
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable biologics, such as monoclonal antibodies and other therapeutic molecules, as well as small molecules a...
GOLDEN STAR
Ticker Change Signal Date
H
HYLS
$41.55
0.289% Jan 15
ROIC
$17.41
0.230% Jan 15
V
VGSH
$58.23
0.0515% Jan 15
F
FALN
$26.87
0.447% Jan 15
F
FTSM
$59.87
0.0668% Jan 15

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE